Treatment to slow Alzheimer’s approved, but €60,000 yearly price not covered by HSE or insurance ‘First in its class’ medication can help patients stay in the early stages of the disease for longer New drug Lecanemab can slow the progress of Alzheimer's disease. Stock image A long-awaited treatment seen as a significant step in the fight against Alzheimer’s disease has finally been approved in Ireland, but it costs €60,000 a year.